Adam Rosenthal

Adam Rosenthal is a seasoned entrepreneur and executive in the biotechnology sector, serving as CEO and Founder of Star Therapeutics, as well as CEO and Co-Founder of Vega Therapeutics since 2018. In addition, Adam Rosenthal is the Co-Founder and Director of Electra Therapeutics, holding the position of Founding CEO. Previously, Adam Rosenthal was the Chief Business Officer at True North Therapeutics, where the company was acquired by Bioverativ in an $825 million transaction. Other notable roles include serving as VP and Head of Corporate Development at iPierian, which was acquired by Bristol-Myers Squibb in a $725 million deal. Early career experience includes a position as Project Leader at The Boston Consulting Group. Adam Rosenthal holds a PhD in Biomedical Engineering and multiple degrees in Electrical Engineering and Computer Science from the Massachusetts Institute of Technology and Harvard Medical School.